Maria Helena Parrinello ретвитнул

CONGRESS | #cGvHD2026 | ORAL PRESENTATION
Maria Helena Parrinello presents data from a study aiming to validate the #cGvHD immune reconstitution (IR) score in a contemporary cohort of patients (N = 166), and evaluate its utility in predicting 5-year outcomes including cGvHD-free survival and relapse (historical cohort, n = 127; contemporary cohort, n = 78).
The IR score offers a practical, clinically applicable tool for long-term allo-HSCT survivors, stratifying 3-year OS from cGvHD onset. Low-risk scores are strongly associated with IST discontinuation at 5 years.
Follow our live feed for more updates: bit.ly/49VYjNJ
Intended for HCPs only. This congress coverage is independently supported by pharmaceutical companies, who are allowed no influence on the content; a full list of supporters can be found on our website.
#GvHD #GvHDsm #MedNews #MedEd




English













